Sex Differences in Phenotype and Tafamidis-Associated Survival in Val122Ile Transthyretin Cardiac Amyloidosis
✍Monfort A, Damy T, Kharoubi M, et al.
📰JACC Heart Failure
Online 25 July 2026 https://doi.org/10.1016/j.jchf.2026.103233

Sex based differences in clinical outcomes among heart failure patients with cardiac amyloidosis on sodium glucose Co-transporter-2 inhibitor therapy: A propensity score-matched analysis.
✍Bashir Z, Saxena R, Yang M, et al.
📰Heart Lung
Online 21 july 2026 https://doi.org/10.1016/j.hrtlng.2026.102895

Bioepidemiology of cardiac amyloidosis
✍Layman AJ, Grogan M, Scott CG, et al.
📰Cardiovascular pathology
Online 21 july 2026 https://doi.org/10.1016/j.carpath.2026.107849

High CA125 levels as a red flag for ATTR Cardiac Amyloidosis.
✍Peiro-Aventín B, Santas E, Ruiz-Cueto M, et al.
📰ESC heart failure
Online 22 july 2026 https://doi.org/10.1093/eschf/xvag199

Automated identification of cardiac amyloidosis using cross-modal neural networks on 99mTc-Pyrophosphate SPECT imaging and clinical data
✍Batı F, Bıçakcı N, Aydın M, Kuş Z, Kiraz B.
📰The international journal of cardiovascular imaging
Online 22 july 2026 https://doi.org/10.1007/s10554-026-03778-7

Cardiac amyloidosis risk across ethnoracial and clinical subgroups: a five-year national study.
✍Itani H, Bou Sanayeh E, Ennab M, et al.
📰American journal of cardiovascular disease
Online 15 june 2026 https://doi.org/10.62347/FNMN7946

Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy
✍Tersalvi G, Bois MC, Scott CG, et al.
📰Circulation. Cardiovascular imaging
Online 23 july 2026 https://doi.org/10.1161/CIRCIMAGING.126.019832

A novel method to classify exercise response in patients with cardiac amyloidosis - The RoMa classification
✍Kösters A, Ermolaev N, Salvioni E, et al.
📰European journal of preventive cardiology
Online 23 july 2026 https://doi.org/10.1093/eurjpc/zwag379

Meta-Analysis of SGLT2 Inhibitors in Transthyretin Cardiac Amyloidosis: Insights by Disease-Modifying Therapy
✍ Bianchi L, Marchionni G, Chendey T, et al.
📰JACC Advances
Online 9 july 2026 https://doi.org/10.1016/j.jacadv.2026.102972

A No-Code, Guideline-Based Custom GPT Outperforms Cardiologists in Response Quality for Cardiac Amyloidosis
✍ Fujiki G, Kodera S, Morita H, Morita H, Takeda N.
📰JACC Advances
Online July 2026 https://doi.org/10.1016/j.jacadv.2026.102918

Cardiovascular Imaging with Total Body PET
✍ Clark LE, Morgan A, Balmforth C, et al.
📰The British journal of radiology
Online 23 July 2026 https://doi.org/10.1093/bjr/tqag165

Frailty status, clinical and functional outcomes in cardiac amyloidosis: a systematic review and meta-analysis
✍ Jiang H, Lim DJ, Khoo CY, et al.
📰EClinicalMedicine
Online 18 July 2026 https://doi.org/10.1016/j.eclinm.2026.104059

Screening for Transthyretin Amyloidosis during Carpal Tunnel release: An opportunity for Early Diagnosis
✍ Jeanneteau J. Bigorre N.
📰The American journal of cardiology
Online 13 july 2026 : https://doi.org/10.1016/j.amjcard.2026.07.007

AI-enhanced electrocardiography as a digital biomarker platform in cardiovascular medicine: clinical applications
✍Venturiello D, Vignaroli W, Nasso G.
📰Open Heart
Online 9 july 2026 : https://doi.org/10.1136/openhrt-2026-004211

Cardio amyloid-artificial intelligence: advanced multi-modal screening for transthyretin cardiac amyloidosis in severe aortic stenosis patients
✍Venturiello D, Vignaroli W, Nasso G.
📰European heart journal. Digital health
Online july 2026 : https://doi.org/10.1136/openhrt-2026-004211

The presence of transthyretin cardiac amyloidosis in patients undergoing coronary artery bypass graft surgery
✍Hewitt K, Sulong S, Starr N, et al.
📰Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
Online july 2026 : https://doi.org/10.1016/j.carpath.2026.107842

A journey through the molecular networks of endomyocardial biopsies to explore ATTR and ALλ cardiac amyloidosis.
✍Viganò R, Lomagno A, Noborn F, et al.
📰iScience
Online 3 july 2026 : https://doi.org/10.1016/j.isci.2026.116573

Impact of SGLT2 inhibitors in cardiac amyloidosis: A systematic review and meta-analysis
✍Nandyal S, Vij A, Varma R, et al.
📰American heart journal plus : cardiology research and practice
Online july 2026 : https://doi.org/10.1016/j.ahjo.2026.100822

Cardiovascular Mortality in Amyloidosis: Long-Term Trends, Disparities, and Projections in the United States
✍Chen Z, Tian Y, Zhang Y.
📰Risk management and healthcare policy
Online 9 july 2026 : https://doi.org/10.2147/RMHP.S607682

Mechanistic Insights Into Metal Binding in the Aggregation Pathway of an Immunoglobulin Light Chain Protein
✍Pradhan T, Sarkar R, Leonhard-Preu J, Schnell AF, Schwierz N, Reif B.
📰Chembiochem : a European journal of chemical biology
Online 14 july 2026 : https://doi.org/10.1002/cbic.70460

Septal thickness to QRS voltage ratio in Lead I/aVR: A simple tool for estimating cardiac amyloid burden
✍Sclafani M, Arcari L, Tini G, et al.
📰 International journal of cardiology
Online july 2026 : https://doi.org/10.1016/j.ijcard.2026.134670

Disease-Modifying Therapies for Hereditary Transthyretin Amyloidosis with Polyneuropathy: Current Status and Future Perspectives
✍Ide T, Yoshikawa M, Koike H.
📰 Neurology and therapy
Online 15 july 2026 : https://doi.org/10.1007/s40120-026-00994-0

Decision-curve analysis and the incremental value of cardiac MRI in transthyretin cardiac amyloidosis
✍Porcari A, Fontana M.
📰 European heart journal. Cardiovascular Imaging
Online 16 july 2026 https://doi.org/10.1093/ehjci/jeag185

Reference Framework for Implementation of Cardiovascular Imaging in Clinical Trials. A Scientific Statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC
✍Surkova E, Gimelli A, Giannopoulos AA, et al.
📰European heart journal. Cardiovascular Imaging
Online 1 july 2026 : https://doi.org/10.1093/ehjci/jeag171

Hepatic multimodal phenotyping in AL amyloidosis with cardiac involvement: the D-Amy-LIPHE study
✍Sessa A, Zaroui A, Charles M, et al.
📰 Amyloid
Online 6 July 2026 : https://doi.org/10.1080/13506129.2026.2694403

Incremental Prognostic Value of Cardiac Magnetic Resonance Beyond Biomarker Staging in Transthyretin Cardiac Amyloidosis
✍Chiou T, Minga I, Subashchandran V, et al.
📰European heart journal. Cardiovascular Imaging
Online 1 july 2026 : https://doi.org/10.1093/ehjci/jeag170

Effects of Acoramidis on Kidney Function in Transthyretin Amyloid CardiomyopathyEffects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy
✍Testani JM, Judge DP, Borlaug BA, et al.
📰Circulation. Heart failure
Online 2 july 2026 : https://doi.org/10.1161/CIRCHEARTFAILURE.126.014656

Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study
✍Magrì D, Ermolaev N, Castiglione V, et al.
📰 ESC heart failure
Online 4 July 2026 : https://doi.org/10.1093/eschf/xvag170

Efficacy and Safety of Low-Frequency Daratumumab Regimen in Systemic Light-Chain Amyloidosis
✍Lin J, Yan H, Meng X, et al.
📰 Cancer medicine
Online 7 July 2026 https://doi.org/10.1002/cam4.72103